Oct 18, 2019
ESSA Announces Changes to its Board of Directors
Sep 19, 2019
ESSA to Present at Ladenburg Thalmann Healthcare Conference
Aug 21, 2019
U.S. FDA Grants XTANDI® (enzalutamide) Application Priority Review for the Treatment of Men with Metastatic Hormone-Sensitive Prostate Cancer
Aug 14, 2019
ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Third Quarter Ended June 30, 2019
Jul 30, 2019
ESSA Announces Court Sanction of the Scheme of Arrangement with Realm Therapeutics
Jul 15, 2019
ESSA Expands Leadership Team by appointing Alessandra Cesano as Chief Medical Officer
Jul 08, 2019
ESSA Provides Update on Court Hearing
Jun 27, 2019
Hypogonadism Market Spotlight 2019 - Clinical Trial Activity is Dominated by Completed Trials, and AbbVie Leads with 8 Completed Trials
Jun 01, 2019
Novartis Kisqali significantly extends life in women with HR+/HER2- advanced breast cancer in MONALEESA-7 trial
May 07, 2019
2025 Outlook for the Global Breast Cancer Therapeutics Market
May 04, 2019
Preclinical Data Highlighting Therapeutic Potential of EPI-7386 Presented at 2019 American Urological Association Annual Meeting
Apr 29, 2019
U.S. FDA accepts New Drug Application and grants Priority Review for darolutamide
Apr 25, 2019
ESSA Pharma to Attend Bloom Burton & Co. Healthcare Investor Conference 2019
Apr 17, 2019
ESSA Pharma Announces Abstract Presentation at the 2019 American Urological Association Annual Meeting
Apr 12, 2019
ESSA Pharma Grants Stock Options
Mar 28, 2019
ESSA Pharma Announces Nomination of EPI-7386 as Lead Clinical Candidate in Metastatic Castration-Resistant Prostate Cancer
Mar 18, 2019
ESSA Pharma to Present at the Oppenheimer 29th Annual Healthcare Conference
Mar 14, 2019
New Potential Treatment Option For Hot Flash Relief For Menopausal Women And Women Taking Tamoxifen®
Mar 14, 2019
ESSA Pharma to Attend the 31st Annual ROTH Conference
Mar 13, 2019
Large Prospective Trial Validates Detection of AR-V7 Biomarker Using Epic Sciences' Platform to Predict Treatment Outcomes for Patients with Advanced Prostate Cancer